- Previous Close
0.0006 - Open
0.0005 - Bid 0.0004 x --
- Ask 0.0006 x --
- Day's Range
0.0005 - 0.0005 - 52 Week Range
0.0005 - 0.0020 - Volume
7,729,000 - Avg. Volume
1,479,560 - Market Cap (intraday)
955,290 - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0020 - Earnings Date Mar 31, 2025 - Apr 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.
www.sohm.com145
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: SHMN
View More
Performance Overview: SHMN
Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHMN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHMN
View MoreValuation Measures
Market Cap
955.29k
Enterprise Value
955.29k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-87.26%
Return on Assets (ttm)
-24.78%
Return on Equity (ttm)
--
Revenue (ttm)
1.3M
Net Income Avi to Common (ttm)
-1.13M
Diluted EPS (ttm)
-0.0020
Balance Sheet and Cash Flow
Total Cash (mrq)
182.56k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-561.14k
Company Insights: SHMN
SHMN does not have Company Insights